Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 20, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 23, 2026
DirectorTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001140361-26-002085
Filed / recorded
Jan 23, 2026, 7:00 AM UTC
Added to OQRO
Oct 6, 2026, 8:46 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Roivant Sciences Ltd.
Issuer CIK
1635088
Ticker
ROIV
Reporting person
Melissa B, Epperly
Relationship
Director
Security
Common Shares
Table
Non-derivative (Table I)
Transaction date
Jan 20, 2026
Transaction code
F
Shares / units
54
Price per share
$22.98
Acquired / disposed
Disposed (D)
Shares owned after
57,665
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.